SV

Street Verdict

Analyst Scorecard

A record of what Marketsmith India Analysis said publicly, with the source. Not advice.

“Bullish on Aster DM Healthcare Limited, recommending a buy between ₹625-640 with a target of ₹720 in two to three months and a stop loss at ₹599. The rationale includes aggressive domestic expansion, merger synergies, and strategic realignment to focus on India, acknowledging execution risks from capex and sector competition.”

Marketsmith India Analysis’s track record (trackable calls only): 322 graded calls · 95% CI 22–32%

Aster DM Healthcare LimitedBullishCalled 05 Sep 2025Graded 21 Oct 2025
Verdict:HIT

How this call is judged

A call is judged on closing prices only: a close at its target is a hit and a close at its stop is a miss. A call that states an entry starts at the first close that reaches it; if none does in the days allowed, it was never triggered, is not graded and counts toward no hit rate.

Entry zone: ₹625–₹640. The call starts at the first close that comes into it.

Target ₹720, stop ₹599, as stated.

Window: 90 days, the time frame the call states ("two to three months").

The target ₹720 was reached on a close before the stop ₹599. Hit.

The grader’s working: R3 TRADE_SETUP: entered ₹638.9 on 2025-09-08 (stated entry ₹625–640 zone, ZONE entry, filled); target ₹720 reached at close ₹722.95 on 2025-10-21. Window 90 days — rule H1: the quote states "two to three months".

How it played out

How this is worked out
Target or stop first
The target was reached on a close before the stop was.
Time to target
The target was reached on a close 30 trading sessions (43 calendar days) after the entry.
Worst close against it
The closing price went as far as 3.91% against the call before the target was reached, measured from the entry price. Closing prices only; an intraday dip is never counted.

From the entry the grade used, on closing prices. This is a record of one past call and is not advice.

Tracking Aster DM Healthcare Limited since this call

1-year tracking window
Read the original articleSee Marketsmith India Analysis’s full track record